Completed PHASE3 INTERVENTIONAL 2-arm NCT01661751

Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003

Phase III Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine

Sponsor: Hualan Biological Engineering, Inc.

Interventions A+C Meningococcal Polysaccharide Vaccine ACYW135 Meningococcal Polysaccharide Vaccine

Updated 5 times since 2017 Last updated: Aug 6, 2012 Started: May 31, 2006 Primary completion: May 31, 2006 Completion: Aug 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Meningitis and is currently completed. Hualan Biological Engineering, Inc. leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hualan Biological Engineering, Inc.

Data source: Hualan Biological Engineering, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.